| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ana M Catafau, Marina Suarez, Santiago Bullich, Jordi Llop, Gianluca Nucci, Roger N Gunn, Claire Brittain, Marc Laruell. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET. NeuroImage. vol 46. issue 2. 2009-06-24. PMID:19233294. |
twenty patients with schizophrenia on monotherapy with risperidone (n=7; 3-9 mg/d), olanzapine (n=5; 5-20 mg/d) or clozapine (n=8; 150-450 mg/d) at stable doses, and ten healthy volunteers (hv) underwent both a [(123)i]ibzm spect and a [(11)c]raclopride pet examinations in random order on different days within a week. |
2009-06-24 |
2023-08-12 |
human |
| Xiaohong Hong, Raymond C K Chan, Xihang Zhuang, Tingyun Jiang, Xiaona Wan, Junqing Wang, Bo Xiao, Hanhui Zhou, Liyun Jiang, Bilan Wen. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia. Schizophrenia research. vol 108. issue 1-3. 2009-06-16. PMID:19106034. |
p50-evoked potential recordings were obtained from 62 normal controls when they entered the study and from 65 patients with first-episode, never-medicated schizophrenia at baseline and after six weeks of different neuroleptic treatments (sulpiride [n=24], risperidone [n=24] and clozapine [n=17]). |
2009-06-16 |
2023-08-12 |
Not clear |
| Zhiyun Wei, Lei Wang, Jiekun Xuan, Ronglin Che, Jing Du, Shengying Qin, Yi Xing, Bo Gu, Lun Yang, Huafang Li, Jun Li, Guoyin Feng, Lin He, Qinghe Xin. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 33. issue 3. 2009-06-16. PMID:19233240. |
association analysis of serotonin receptor 7 gene (htr7) and risperidone response in chinese schizophrenia patients. |
2009-06-16 |
2023-08-12 |
human |
| Zhiyun Wei, Lei Wang, Jiekun Xuan, Ronglin Che, Jing Du, Shengying Qin, Yi Xing, Bo Gu, Lun Yang, Huafang Li, Jun Li, Guoyin Feng, Lin He, Qinghe Xin. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 33. issue 3. 2009-06-16. PMID:19233240. |
in this study, we genotyped ten single nucleotide polymorphisms (snps) distributed throughout the htr7 gene and analyzed six of them for association with the reduction of brief psychiatric rating scale (bprs) scores in drug-naive chinese schizophrenia patients, following an eight-week period of risperidone monotherapy. |
2009-06-16 |
2023-08-12 |
human |
| M Riedel, F X Eich, H J Mölle. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients. European psychiatry : the journal of the Association of European Psychiatrists. vol 24. issue 3. 2009-06-10. PMID:19070995. |
the primary objective of this randomised, active-controlled, parallel group, double-blind study was to evaluate the tolerability of treatment with either amisulpride or risperidone in elderly patients with schizophrenia aged over 65 years; evaluation of efficacy was a secondary objective. |
2009-06-10 |
2023-08-12 |
Not clear |
| J Peuskens, B Gillain, D De Graeve, B Van Vleymen, A Alber. Belgian Schizophrenia Outcome Survey - results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol. European psychiatry : the journal of the Association of European Psychiatrists. vol 24. issue 3. 2009-06-10. PMID:19118983. |
belgian schizophrenia outcome survey - results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol. |
2009-06-10 |
2023-08-12 |
Not clear |
| Virginia Stauffer, Haya Ascher-Svanum, Lin Liu, Tamara Ball, Robert Conle. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. BMC psychiatry. vol 9. 2009-06-10. PMID:19335905. |
this post-hoc analysis describes maintenance of response over 24 or 28 weeks in people treated for schizophrenia with olanzapine, risperidone, quetiapine, ziprasidone, or aripiprazole. |
2009-06-10 |
2023-08-12 |
Not clear |
| Luca Pani, Giorgio Marches. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release. Expert opinion on drug delivery. vol 6. issue 3. 2009-05-28. PMID:19317589. |
clinical trials confirmed that paliperidone er is efficacious in the management of schizophrenia and well tolerated, however no direct clinical comparisons between paliperidone er and immediate-release formulations of risperidone have been conducted to date. |
2009-05-28 |
2023-08-12 |
Not clear |
| Bun-Hee Lee, Yong-Ku Ki. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology. vol 59. issue 1. 2009-05-22. PMID:19270464. |
increased plasma brain-derived neurotropic factor, not nerve growth factor-beta, in schizophrenia patients with better response to risperidone treatment. |
2009-05-22 |
2023-08-12 |
Not clear |
| Bun-Hee Lee, Yong-Ku Ki. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology. vol 59. issue 1. 2009-05-22. PMID:19270464. |
we examined the plasma levels of these 2 factors in schizophrenia patients at the time of admission and after 6 weeks of treatment with risperidone. |
2009-05-22 |
2023-08-12 |
Not clear |
| Vishal Madaa. Risperidone: a review of efficacy studies in adolescents with schizophrenia. Drugs of today (Barcelona, Spain : 1998). vol 45. issue 1. 2009-05-20. PMID:19271032. |
risperidone: a review of efficacy studies in adolescents with schizophrenia. |
2009-05-20 |
2023-08-12 |
Not clear |
| Vishal Madaa. Risperidone: a review of efficacy studies in adolescents with schizophrenia. Drugs of today (Barcelona, Spain : 1998). vol 45. issue 1. 2009-05-20. PMID:19271032. |
risperidone has been approved by the food and drug administration for the treatment of schizophrenia in the adolescent population. |
2009-05-20 |
2023-08-12 |
Not clear |
| Vishal Madaa. Risperidone: a review of efficacy studies in adolescents with schizophrenia. Drugs of today (Barcelona, Spain : 1998). vol 45. issue 1. 2009-05-20. PMID:19271032. |
this brief article provides an overview of risperidone's pharmacological profile followed by information on the double-blind trials that have resulted in the approval of risperidone for the treatment of adolescent schizophrenia. |
2009-05-20 |
2023-08-12 |
Not clear |
| Annemieke De Ridder, Diana De Graev. Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach. PharmacoEconomics. vol 27. issue 1. 2009-05-12. PMID:19178125. |
comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach. |
2009-05-12 |
2023-08-12 |
Not clear |
| Annemieke De Ridder, Diana De Graev. Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach. PharmacoEconomics. vol 27. issue 1. 2009-05-12. PMID:19178125. |
to estimate the cost effectiveness of olanzapine and risperidone for the treatment of schizophrenia in belgium. |
2009-05-12 |
2023-08-12 |
Not clear |
| Annemieke De Ridder, Diana De Graev. Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach. PharmacoEconomics. vol 27. issue 1. 2009-05-12. PMID:19178125. |
clinical investigators assigned 265 patients with schizophrenia to either olanzapine (n = 136) or risperidone (n = 129). |
2009-05-12 |
2023-08-12 |
Not clear |
| Donald E Addington, Alain Labelle, Jayashri Kulkarni, Gordon Johnson, Antony Loebel, Francine S Mande. A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 54. issue 1. 2009-05-08. PMID:19175979. |
a comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. |
2009-05-08 |
2023-08-12 |
Not clear |
| Donald E Addington, Alain Labelle, Jayashri Kulkarni, Gordon Johnson, Antony Loebel, Francine S Mande. A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 54. issue 1. 2009-05-08. PMID:19175979. |
this randomized, double-blind, multicentre extension study compared the efficacy, tolerability, and safety of ziprasidone and risperidone for schizophrenia or schizoaffective disorder. |
2009-05-08 |
2023-08-12 |
Not clear |
| L Greenbaum, R C Smith, A Rigbi, R Strous, O Teltsh, K Kanyas, M Korner, D Lancet, E Ben-Asher, B Lere. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region. The pharmacogenomics journal. vol 9. issue 2. 2009-05-07. PMID:18347610. |
eps were rated in 184 us patients with schizophrenia (115 african americans, 69 caucasian) treated for at least a month with typical antipsychotic drugs (n=45), risperidone (n=46), olanzapine (n=50) or clozapine (n=43). |
2009-05-07 |
2023-08-12 |
Not clear |
| Daniel E Casey, David G Daniel, Carol Tamminga, John M Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco, Mario Saltarell. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 34. issue 5. 2009-05-07. PMID:19052541. |
divalproex er combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. |
2009-05-07 |
2023-08-12 |
Not clear |